K. Thompson

发表

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate‐severe flares: a phase 2A pilot multi‐center, randomized, double‐blind, sham‐controlled trial

John T. Chang, C. Siegel, J. Buckey, 2018, The American Journal of Gastroenterology.

Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications

D. Rubin, A. Girgis, A. Sechi, 2014, Inflammatory bowel diseases.

Depressive cognitions, maternal attitudes and postnatal depression

D. Bendell, K. Thompson, 2014 .

Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits

C. Siegel, Shawn X Li, K. Thompson, 2017, Inflammatory bowel diseases.

Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Heather B. Blunt, M. Dubinsky, C. Siegel, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical variables as prognostic tools in pediatric‐onset ulcerative colitis: A retrospective cohort study

W. D. Jackson, S. Guthery, E. Scaife, 2011, Inflammatory bowel diseases.

A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables

M. Silverberg, S. Targan, D. McGovern, 2016, Alimentary pharmacology & therapeutics.

Hyperbaric Oxygen Therapy is Safe and Effective for Hospitalized Ulcerative Colitis Patients Suffering from Moderate-Severe Flares: A Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial

John T. Chang, C. Siegel, J. Buckey, 2017 .

Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial

M. Dubinsky, M. Regueiro, Todd A MacKenzie, 2022, Alimentary pharmacology & therapeutics.

Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn’s Disease

C. Siegel, L. Beaugerie, E. Louis, 2021, Clinical Gastroenterology and Hepatology.

Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy.

E. Louis, C. Siegel, L. Beaugerie, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

International Differences in Gastroenterologists' Perspective on Stopping Therapy for Patients with Crohn's Disease

E. Louis, C. Siegel, J. Colombel, 2017 .

DOP015 International differences in gastroenterologists' perspective on stopping therapy for patients with Crohn's disease.

E. Louis, C. Siegel, J. Colombel, 2017, Journal of Crohn's & colitis.

Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications.

C. Siegel, J. Koliani-Pace, K. Thompson, 2019, Inflammatory bowel diseases.

Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis

C. Siegel, V. Baptista, K. Thompson, 2016, Journal of clinical gastroenterology.

Participation in a Traditional Mentorship Program: A Multiple Case Study of Alternatively Certified Teachers

K. Thompson, 2018 .

Su1312 A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables

Alexander N. Levy, M. Silverberg, M. Dubinsky, 2014 .